Skip to main content
main-content

Zeitschrift

Journal of Inherited Metabolic Disease

Journal of Inherited Metabolic Disease 2/2001

Sonderheft 2/2001

Inhaltsverzeichnis ( 20 Artikel )

01.04.2001 | Foreword | Sonderheft 2/2001

Foreword

Hans Aerts, Michael Beck, Timothy Cox

01.04.2001 | Sonderheft 2/2001

An historical overview of Fabry disease

H. Fabry

01.04.2001 | Commentary | Sonderheft 2/2001

Commentary

R. O. Brady

01.04.2001 | Sonderheft 2/2001

Natural history of Fabry disease in affected males and obligate carrier females

K. D. MacDermot, A. Holmes, A. H. Miners

01.04.2001 | Sonderheft 2/2001

Natural history of Fabry disease in males: preliminary observations

R. Schiffmann

01.04.2001 | Sonderheft 2/2001

Enzyme replacement therapy in Fabry disease

R. O. Brady, G. J. Murray, D. F. Moore, R. Schiffmann

01.01.2001 | Sonderheft 2/2001

Gene therapy for Fabry disease

C. Sitaskas, J. A. Medin

01.04.2001 | Commentary | Sonderheft 2/2001

Commentary

J. J. Hopwood

01.04.2001 | Sonderheft 2/2001

Variable clinical presentation in lysosomal storage disorders

M. Beck

01.04.2001 | Sonderheft 2/2001

Are there useful biochemical markers of disease activity in lysosomal storage diseases?

B. Winchester

01.04.2001 | Sonderheft 2/2001

Is genotype determination useful in predicting the clinical phenotype in lysosomal storage diseases?

I. Maire

01.04.2001 | Sonderheft 2/2001

Commentary

J.-P. Grünfeld

01.04.2001 | Sonderheft 2/2001

Renal pathological changes in Fabry disease

A. Sessa, M. Meroni, G. Battini, A. Maglio, P. L. Brambilla, M. Bertella, M. Nebuloni, F. Pallotti, F. Giordano, B. Bertagnolio, A. Tosoni

01.04.2001 | Sonderheft 2/2001

Renal disease in Fabry patients

J.-P. Grünfeld, O. Lidove, D. Joly, F. Barbey

01.04.2001 | Sonderheft 2/2001

Cardiac manifestations in Fabry disease

A. Linhart, J.-C. Lubanda, T. Palecek, J. Bultas, D. Karetová, J. Ledvinová, M. Elleder, M. Aschermann

01.04.2001 | Sonderheft 2/2001

Commentary

T. Cox

01.04.2001 | Sonderheft 2/2001

Lessons learned from the development of enzyme therapy for Gaucher disease

J. A. Barranger, E. O'Rourke

01.04.2001 | Sonderheft 2/2001

Clinically relevant therapeutic endpoints in type I Gaucher disease

C. E. M. Hollak, M. Maas, J. M. Aerts

01.04.2001 | Sonderheft 2/2001

Gaucher disease: understanding the molecular pathogenesis of sphingolipidoses

T. M. Cox

01.04.2001 | Sonderheft 2/2001

Remaining problems in the management of patients with Gaucher disease

A. Erikson

Aktuelle Ausgaben

Neu im Fachgebiet Innere Medizin

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Innere Medizin und bleiben Sie gut informiert – ganz bequem per eMail.

© Springer Medizin 

Bildnachweise